Straits Times Index
3,288.50 -4.19 (-0.13%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,182.23 +419.20 (+2.36%) FTSE 100
8,146.38 +25.14 (+0.31%) Bitcoin USD
57,736.70 -835.41 (-1.43%) CMC Crypto 200
1,262.73 -8.01 (-0.63%)
AstraZeneca PLC (AZN)
After hours:
| Previous close | 75.88 |
| Open | 76.37 |
| Bid | 76.36 x 700 |
| Ask | 76.51 x 1000 |
| Day's range | 75.96 - 76.80 |
| 52-week range | 60.47 - 76.80 |
| Volume | |
| Avg. volume | 6,526,681 |
| Market cap | 236.905B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 37.83 |
| EPS (TTM) | 2.02 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 1.45 (1.90%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | 81.91 |
Business WireAstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
WILMINGTON, Del., May 01, 2024--AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Diego, CA from May 17 - 22, 2024. The company will present 59 abstracts, including 12 late-breaking posters, with a focus on unmet needs in chronic obstructive pulmonary disease (COPD), severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA), as
Insider MonkeyAstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expectations were $1.22. AstraZeneca PLC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning to those joining […]
BenzingaAstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in numerous cases. Lawyers representing the plaintiffs argue that the vaccine resulted in side effects for a small number of families, including brain injuries and fatalities. AstraZeneca, while contesting the claims, has acknowledged in court documents that its vaccine can, in rare instances, cause Thro
